BIVDA welcomes the fully agreed text of the UK–US pharmaceutical partnership, which delivers preferential terms for medical technology exports and sets out a pathway towards mutual recognition of medical device approvals. These measures mark an important step in reducing barriers to trade and supporting faster access to innovative health technologies across both markets. The agreement confirms that UK medical technology…
Ben KempApril 8, 2026